1
TITLE: Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases  Full Text
AUTHORS: Maria E Sheean; Eva Malikova; Dinah Duarte; Giuseppe Capovilla; Laura Fregonese; Matthias P Hofer; Armando Magrelli; Segundo Mariz; Fernando Mendez Hermida; Robert Nistico; Tim Leest; Nikolaos V Sipsas; Stelios Tsigkos; Dinko Vitezic; Kristina Larsson; Bruno Sepodes; Violeta Stoyanova Beninska;
PUBLISHED: 2020, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 25, ISSUE: 2
INDEXED IN: Scopus WOS
2
TITLE: Defining orphan conditions in the context of the European orphan regulation: challenges and evolution
AUTHORS: Daniel J O'Connor; Maria E Sheean; Matthias P Hofer; Stelios Tsigkos; Segundo Mariz; Laura Fregonese; Kristina Larsson; Virginie Hivert; Kerstin Westermark; Frauke Naumann Winter; Violeta Stoyanova Beninska; Ingeborg Barisic; Giuseppe Capovilla; Armando Magrelli; Bruno Sepodes;
PUBLISHED: 2019, SOURCE: NATURE REVIEWS DRUG DISCOVERY, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
3
TITLE: Establishing rarity in the context of orphan medicinal product designation in the European Union  Full Text
AUTHORS: Stelios Tsigkos; Matthias Philipp Hofer; Maria Elzbieta Sheean; Segundo Mariz; Kristina Larsson; Frauke Naumann Winter; Laura Fregonese; Bruno Sepodes;
PUBLISHED: 2018, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 23, ISSUE: 3
INDEXED IN: WOS
4
TITLE: Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union  Full Text
AUTHORS: Stelios Tsigkos; Segundo Mariz; Jordi Llinares; Laura Fregonese; Stiina Aarum; Frauke Naumann-Winter; Kerstin Westermark; Bruno Sepodes;
PUBLISHED: 2015, SOURCE: Orphanet Journal of Rare Diseases - Orphanet J Rare Dis, VOLUME: 10, ISSUE: 1
INDEXED IN: CrossRef
5
TITLE: Establishing medical plausibility in the context of orphan medicines designation in the European Union (vol 9, 175, 2014)  Full Text
AUTHORS: Stelios Tsigkos; Segundo Mariz; Jordi Llinares; Laura Fregonese; Stiina Aarum; Frauke Naumann Winter; Kerstin Westermark; Bruno Sepodes;
PUBLISHED: 2015, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 10
INDEXED IN: WOS
6
TITLE: Use of biomarkers in the context of orphan medicines designation in the European Union  Full Text
AUTHORS: Stelios Tsigkos; Jordi Llinares; Segundo Mariz; Stiina Aarum; Laura Fregonese; Bozenna Dembowska Baginska; Rembert Elbers; Pauline Evers; Tatiana Foltanova; Andre Lhoir; Ana Correa Nunes; Daniel O'Connor; Albertha Voordouw; Kerstin Westermark; Bruno Sepodes;
PUBLISHED: 2014, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
7
TITLE: The orphan framework as a new opportunity: an expert opinion
AUTHORS: Segundo Mariz; Stelios Tsigkos; Laura Fregonese; Stiina Aarum; Eleonora Dehlink; Jordi Llinares; Bruno Sepodes;
PUBLISHED: 2014, SOURCE: EXPERT OPINION ON ORPHAN DRUGS, VOLUME: 2, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef
8
TITLE: Establishing medical plausibility in the context of orphan medicines designation in the European Union  Full Text
AUTHORS: Stelios Tsigkos; Segundo Mariz; Jordi Llinares; Laura Fregonese; Stiina Aarum; Naumann Winter Frauke; Kerstin Westermark; Bruno Sepodes;
PUBLISHED: 2014, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef